Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

NCT06465810 · clinicaltrials.gov ↗

RECRUITING

Status

1850

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin Amyloidosis
ATTR-CM
ATTRv-PN
ATTR
ATTR-Mixed
hATTR

Interventions

DRUG: Treatment of transthyretin (ATTR) amyloidosis in observational study setting

Sponsor

AstraZeneca

Collaborators

[object Object]